Just saw Aquestive Therapeutics announced a new Chief Medical Officer - Matthew Greenhawt taking the role. Guy's got serious credentials, like he was heading the Asthma and Allergy Foundation before this and was a professor at Colorado Children's Hospital. Apparently Matthew's known for his work in food allergies and anaphylaxis research, which seems pretty relevant for a pharma company. Stock jumped to $3.90 in pre-market trading, up about 0.5%. Interesting timing for this kind of leadership move. Makes you wonder what direction they're heading with their pipeline.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin